Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer or Mild Cognitive Impairment”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Early research (Phase 1)Looking for participantsNCT06247345
What this trial is testing

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Who this might be right for
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc. 73
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Testing effectiveness (Phase 2)Looking for participantsNCT04804241
What this trial is testing

Senicapoc in Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of California, Davis 55
Not applicableStudy completedNCT03070821
What this trial is testing

Therapy of Alzheimer's Disease With Neurofeedback

Who this might be right for
Alzheimer Dementia (AD)Elderly
University Hospital, Aachen 30
Not applicableWithdrawnNCT04901494
What this trial is testing

SSRI's and the Rate of Progression From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentDementiaAlzheimer Disease
Ohio State University
Testing effectiveness (Phase 2)Looking for participantsNCT06199037
What this trial is testing

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 45
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Early research (Phase 1)Looking for participantsNCT07169630
What this trial is testing

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer s DiseaseMild Cognitive ImpairmentHealthy
National Institute of Mental Health (NIMH) 90
Early research (Phase 1)Not Yet RecruitingNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Testing effectiveness (Phase 2)Study completedNCT01202994
What this trial is testing

Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET

Who this might be right for
Alzheimer's Disease
University of Utah 27
Testing effectiveness (Phase 2)Looking for participantsNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics (Hong Kong) Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT01518374
What this trial is testing

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Avid Radiopharmaceuticals 1,768
Very early researchNot Yet RecruitingNCT07214974
What this trial is testing

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

Who this might be right for
Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease Dementia+7 more
Noah Tech, Corp. 600
Not applicableUnknownNCT02778581
What this trial is testing

Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment

Who this might be right for
Cognitive ImpairmentsAlzheimer Disease
Team Foods Colombia S.A. 110
Not applicableStudy completedNCT02843529
What this trial is testing

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentMemory Disorders+3 more
Altoida 548
Very early researchLooking for participantsNCT04123314
What this trial is testing

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Depressive SymptomsDepressionAlzheimer Disease+1 more
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT04931459
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 65
Not applicableStudy completedNCT04733989
What this trial is testing

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early OnsetMild Cognitive Impairment+3 more
GAP Innovations, PBC 1,002
Testing effectiveness (Phase 2)Study completedNCT02423200
What this trial is testing

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Alzheimer's Disease
EIP Pharma Inc 16
Testing effectiveness (Phase 2)Study completedNCT04602624
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Dementia
Supernus Pharmaceuticals, Inc. 26
Load More Results